Form 8-K - Current report:
SEC Accession No. 0000950170-24-092779
Filing Date
2024-08-07
Accepted
2024-08-07 16:10:09
Documents
12
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alec-20240807.htm   iXBRL 8-K 40338
2 EX-99.1 alec-ex99_1.htm EX-99.1 152433
  Complete submission text file 0000950170-24-092779.txt   318645

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20240807.xsd EX-101.SCH 24836
14 EXTRACTED XBRL INSTANCE DOCUMENT alec-20240807_htm.xml XML 4686
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 241183747
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)